newsfilter
← Latest News
PR Newswire·

MetaVia Regains Compliance with Nasdaq Minimum Bid Price Requirement

MetaVia Inc. (Nasdaq: MTVA), a clinical-stage biotechnology company focused on transforming cardiometabolic diseases, today announced that on...